| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 37 |
| 1 | INFLIXIMAB | 22 |
| 2 | METHOTREXATE SODIUM | 22 |
| 3 | METHOTREXATE | 19 |
| 4 | CISPLATIN | 16 |
| 5 | ETANERCEPT | 16 |
| 6 | ETOPOSIDE | 16 |
| 7 | RITUXIMAB | 15 |
| 8 | DEXAMETHASONE | 14 |
| 9 | DEXAMETHASONE 1.5 MG | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SENNOSIDES, DOCUSATE SODIUM | 1 | 0.0250 |
| 1 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 2 | BARICITINIB | 6 | 0.0020 |
| 3 | APREPITANT | 13 | 0.0017 |
| 4 | FOSAPREPITANT DIMEGLUMINE | 13 | 0.0009 |
| 5 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 6 | CLOMIPRAMINE HYDROCHLORIDE | 3 | 0.0007 |
| 7 | AMISULPRIDE | 4 | 0.0007 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 4 | 0.0005 |
| 9 | CALCIUM FOLINATE | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 14 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 10 | 0.0001 |